These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 4137948)

  • 1. Studies on the biological and antigenic properties of ESP-1 type C virus particles.
    Eckner RJ; Priori ES; Mirand EA; Dmochowski L
    Cancer Res; 1974 Oct; 34(10):2521-9. PubMed ID: 4137948
    [No Abstract]   [Full Text] [Related]  

  • 2. ESP-1 helper virus: characterization of type-specific envelope specificities distinct from those of the murine leukemia viruses.
    Eckner RJ; Priori ES; Mirand EA; Dmochowski L
    Bibl Haematol; 1975; (40):607-9. PubMed ID: 51638
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the FMR antigen.
    Lilly F; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
    [No Abstract]   [Full Text] [Related]  

  • 4. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 7. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
    Hanna MG; Ihle JN; Lee JC
    Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization of mammalian type C virus species-specific (gs-1) and interspecies-specific (gs-3) antigenic determinants with the indirect immunoperoxidase technique and light microscopy.
    Girardi A; Hampar B; Hsu KC; Oroszlan S; Hornberger E; Kelloff G; Gilden RV
    J Immunol; 1973 Jul; 111(1):152-6. PubMed ID: 4123368
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 11. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the neutralization of the oncogenicity of Friend, Moloney, and Rauscher viruses.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1968 May; 28(5):942-6. PubMed ID: 4870883
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of the virions in the in vitro L1210(V) leukemia cell lines by morphological, virological, and immunological techniques.
    Chen PL; Hutchison DJ; Sarkar NH; Kramarsky B; Moore DH
    Cancer Res; 1975 Mar; 35(3):718-28. PubMed ID: 163689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of immune response to friend virus-induced leukemia.
    Ting CC; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1676-83. PubMed ID: 4134291
    [No Abstract]   [Full Text] [Related]  

  • 15. Xenotropic C-type viruses and autoimmune disease.
    Levy JA
    J Rheumatol; 1975 Jun; 2(2):135-48. PubMed ID: 50450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific transplantation antigens in reticulum cell sarcomas and lymphomas induced by the friend virus complex.
    Fieldsteel AH; Dawson PJ; Kurahara C
    Cancer Res; 1973 Mar; 33(3):551-8. PubMed ID: 4347715
    [No Abstract]   [Full Text] [Related]  

  • 18. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses.
    Lee JC; Ihle JN
    J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
    Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
    J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.